You are here

HUN-REN-DE Sejtbiológiai és Jelátvitel Kutatócsoport

HUN-REN-DE Sejtbiológiai és Jelátvitel Kutatócsoport

Name: HUN-REN-DE Sejtbiológiai és Jelátvitel Kutatócsoport

Publication list

Uploaded publications:
27
Publications in DEA:
27
OA:
23
Date range:
2022-2024
2024
  1. Szeőcs, D., Vida, B., Petővári, G., Póliska, S., Janka, E., Sipos, A., Uray, K., Sebestyén, A., Krasznai, Z., Bai, P.: Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFbeta-ERK signalling.
    GeroScience. 46 (4), 3581-3597, 2024.
    Journal metrics:
    Q1 Aging (2023)
    Q1 Cardiology and Cardiovascular Medicine (2023)
    D1 Complementary and Alternative Medicine (2023)
    Q1 Geriatrics and Gerontology (2023)
    D1 Veterinary (miscellaneous) (2023)
  2. Kállai, J., Gindele, R., Pénzes-Daku, K., Balogh, G., Kissné Bogáti, R., Bécsi, B., Katona, É., Oláh, Z., Ilonczai, P., Boda, Z., Róna-Tas, Á., Nemes, L., Marton, I., Bereczky, Z.: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
    Int. J. Mol. Sci. 25 (5), 1-19, 2024.
    Journal metrics:
    Q2 Catalysis (2023)
    Q1 Computer Science Applications (2023)
    D1 Inorganic Chemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
    Q2 Molecular Biology (2023)
    D1 Organic Chemistry (2023)
    Q1 Physical and Theoretical Chemistry (2023)
    D1 Spectroscopy (2023)
  3. Schwarcz, S., Nyerges, P., Bíró, T., Janka, E., Bai, P., Mikó, E.: Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells.
    Molecules. 29 (13), 1-16, 2024.
    Journal metrics:
    Q1 Analytical Chemistry (2023)
    Q1 Chemistry (miscellaneous) (2023)
    Q2 Drug Discovery (2023)
    Q2 Medicine (miscellaneous) (2023)
    Q3 Molecular Medicine (2023)
    Q2 Organic Chemistry (2023)
    Q1 Pharmaceutical Science (2023)
    Q2 Physical and Theoretical Chemistry (2023)
  4. Ujlaky-Nagy, L., Szöllősi, J., Vereb, G.: Disrupting EGFR-HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome.
    Int. J. Mol. Sci. 25 (11), 1-20, 2024.
    Journal metrics:
    Q2 Catalysis (2023)
    Q1 Computer Science Applications (2023)
    D1 Inorganic Chemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
    Q2 Molecular Biology (2023)
    D1 Organic Chemistry (2023)
    Q1 Physical and Theoretical Chemistry (2023)
    D1 Spectroscopy (2023)
  5. Kolostyák, Z., Bojcsuk, D., Baksa, V., Máthéné Szigeti, Z., Bene, K., Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., Tzerpos, P., Berger, W., Villabona-Rueda, A., Varga, Z., Kovács, T., Patsalos, A., Pap, A., Vámosi, G., Bai, P., Dezső, B., Spite, M., D'Alessio,, F., Szatmári, I., Nagy, L.: EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
    JCI Insight. 9 (17), 1-21, 2024.
    Journal metrics:
    D1 Medicine (miscellaneous) (2023)
  6. Mikó, E., Sipos, A., Tóth, E., Lehoczki, A., Fekete, M., Sebő, É., Kardos, G., Bai, P.: Guideline for designing microbiome studies in neoplastic diseases.
    GeroScience. 46 (5), 4037-4057, 2024.
    Journal metrics:
    Q1 Aging (2023)
    Q1 Cardiology and Cardiovascular Medicine (2023)
    D1 Complementary and Alternative Medicine (2023)
    Q1 Geriatrics and Gerontology (2023)
    D1 Veterinary (miscellaneous) (2023)
  7. Piga, M., Varga, Z., Fehér, Á., Papp, F., Korpos, É., Bangera, K., Frlan, R., Ilas, J., Dernovsek, J., Tomasic, T., Zidar, N.: Identification of a Novel Structural Class of H1 Inhibitors by Structure-Based Virtual Screening.
    J. Chem Inf. Model. 64 (12), 4850-4862, 2024.
    Journal metrics:
    Q1 Chemical Engineering (miscellaneous) (2023)
    Q1 Chemistry (miscellaneous) (2023)
    Q1 Computer Science Applications (2023)
    D1 Library and Information Sciences (2023)
  8. Kormos, J., Daróczi, L., Szöllősi, J., Mátyus, L., Jenei, A.: Novel transmission electron microscopic method to quantify protein clustering on the cell surface.
    Curr. Protoc. 4 (5), 1-14, 2024.
    Journal metrics:
    Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
    D1 Health Informatics (2023)
    Q1 Immunology and Microbiology (miscellaneous) (2023)
    D1 Medical Laboratory Technology (2023)
    Q1 Neuroscience (miscellaneous) (2023)
    D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (2023)
  9. Sturniolo, I., Váróczy, C., Regdon, Z., Türk-Mázló, A., Muzsai, S., Bácsi, A., Intili, G., Hegedűs, C., Boothby, M., Holechek, J., Ferraris, D., Schüler, H., Virág, L.: PARP14 contributes to the development of the tumor-associated macrophage phenotype.
    Int. J. Mol. Sci. 25 (7), 1-21, 2024.
    Journal metrics:
    Q2 Catalysis (2023)
    Q1 Computer Science Applications (2023)
    D1 Inorganic Chemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
    Q2 Molecular Biology (2023)
    D1 Organic Chemistry (2023)
    Q1 Physical and Theoretical Chemistry (2023)
    D1 Spectroscopy (2023)
  10. Oit-Wiscombe, I., Virág, L., Kilk, K., Soomets, U., Altraja, A.: Pattern of Expression of Genes Involved in Systemic Inflammation and Glutathione Metabolism Reveals Exacerbation of COPD.
    Antioxidants. 13 (8), 1-14, 2024.
    Journal metrics:
    Q1 Biochemistry (2023)
    Q2 Cell Biology (2023)
    Q1 Clinical Biochemistry (2023)
    D1 Food Science (2023)
    Q2 Molecular Biology (2023)
    Q1 Physiology (2023)
  11. Sturniolo, I., Váróczy, C., Bede, Á., Hegedűs, C., Demény, M., Virág, L.: Quantifying antibody-dependent cellular cytotoxicity in a tumor spheroid model: application for drug discovery.
    J. Vis. Exp. 206 1-14, 2024.
    Journal metrics:
    Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
    Q2 Chemical Engineering (miscellaneous) (2023)
    Q3 Immunology and Microbiology (miscellaneous) (2023)
    Q3 Neuroscience (miscellaneous) (2023)
  12. Szántó, M., Yélamos, J., Bai, P.: Specific and shared biological functions of PARP2-is PARP2 really a lil' brother of PARP1?.
    Expert Rev. Mol. Med. 26 1-21, 2024.
    Journal metrics:
    Q1 Molecular Biology (2023)
    Q1 Molecular Medicine (2023)
  13. Schwarcz, S., Kovács, P., Nyerges, P., Ujlaki, G., Sipos, A., Uray, K., Bai, P., Mikó, E.: The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma.
    Cell Death Discov. 10 (1), 1-12, 2024.
    Journal metrics:
    Q1 Cancer Research (2023)
    Q1 Cell Biology (2023)
    Q1 Cellular and Molecular Neuroscience (2023)
    Q1 Immunology (2023)
  14. Papp, H., Tóth, E., Bóvári-Biri, J., Bánfai, K., Juhász, P., Mahdi, M., Russo, L., Bajusz, D., Sipos, A., Petri, L., Szalai, T., Kemény, Á., Madai, M., Kuczmog, A., Batta, G., Mózner, O., Vaskó, D., Hirsch, E., Bohus, P., Méhes, G., Tőzsér, J., Curtin, N., Helyes, Z., Tóth, A., Hoch, N., Jakab, F., Keserű, G., Pongrácz, J., Bai, P.: The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.
    Br. J. Pharmacol. 181 (23), 4782-4803, 2024.
    Journal metrics:
    D1 Pharmacology (2023)
2023
  1. Szántó, G., Fehér, Á., Korpos, É., Gyöngyösi, A., Kállai, J., Mészáros, B., Óvári, K., Lányi, Á., Panyi, G., Varga, Z.: 5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel.
    Pharmaceuticals (Basel). 16 (5), 1-15, 2023.
    Journal metrics:
    Q2 Drug Discovery
    Q2 Molecular Medicine
    Q1 Pharmaceutical Science
  2. Skopál, A., Ujlaki, G., Gerencsér, A., Bankó, C., Bacsó, Z., Ciruela, F., Virág, L., Haskó, G., Kókai, E.: Adenosine A2A Receptor Activation Regulates Niemann-Pick C1 Expression and Localization in Macrophages.
    Curr. Issues Mol. Biol. 45 (6), 4948-4969, 2023.
    Journal metrics:
    Q2 Medicine (miscellaneous)
    Q2 Microbiology
    Q2 Microbiology (medical)
    Q3 Molecular Biology
  3. Guti, E., Bede, Á., Váróczy, C., Hegedűs, C., Demény, M., Virág, L.: High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds.
    JoVE. 198 1-12, 2023.
    Journal metrics:
    Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous)
    Q2 Chemical Engineering (miscellaneous)
    Q3 Immunology and Microbiology (miscellaneous)
    Q3 Neuroscience (miscellaneous)
  4. Ujlaki, G., Kovács, T., Vida, A., Kókai, E., Rauch, B., Schwarcz, S., Mikó, E., Janka, E., Sipos, A., Hegedűs, C., Uray, K., Nagy, P., Bai, P.: Identification of bacterial metabolites modulating breast cancer cell proliferation and epithelial-mesenchymal transition.
    Molecules. 28 (15), 1-18, 2023.
    Journal metrics:
    Q1 Analytical Chemistry
    Q1 Chemistry (miscellaneous)
    Q2 Drug Discovery
    Q2 Medicine (miscellaneous)
    Q3 Molecular Medicine
    Q2 Organic Chemistry
    Q1 Pharmaceutical Science
    Q2 Physical and Theoretical Chemistry
  5. Takács, R., Juhász, T., Katona, É., Somogyi, C., Vágó, J., Hajdú, T., Barna, K., Nagy, P., Zákány, R., Matta, C.: Isolation and Micromass Culturing of Primary Chicken Chondroprogenitor Cells for Cartilage Regeneration.
    Curr. Protoc. 3 (7), 1-29, 2023.
    Journal metrics:
    Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
    D1 Health Informatics
    Q1 Immunology and Microbiology (miscellaneous)
    D1 Medical Laboratory Technology
    Q1 Neuroscience (miscellaneous)
    D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  6. Antal, D., Pór, Á., Kovács, I., Dull, K., Póliska, S., Ujlaki, G., Demény, M., Szöllősi, A., Kiss, B., Szegedi, A., Bai, P., Szántó, M.: PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes.
    J. Mol. Med. (Berl). 101 (8), 987-999, 2023.
    Journal metrics:
    D1 Drug Discovery
    Q1 Genetics (clinical)
    Q1 Molecular Medicine
Show all
updated: 2024-11-14, 01:31

SCImago quartiles of
scientific journal articles

Number of scientific articles: 27
Q1/D1 16 (59.3%)
Q1 24 (88.9%)
Q2 3 (11.1%)
-
OK

SCImago subject areas and categories

Biochemistry, Genetics and Molecular Biology (21)
Molecular Biology (7)
Biochemistry, Genetics and Molecular Biology (miscellaneous) (5)
Molecular Medicine (5)
Cell Biology (3)
Aging (2)
Cancer Research (2)
Biochemistry (1)
Clinical Biochemistry (1)
Physiology (1)
Medicine (17)
Medicine (miscellaneous) (8)
Health Informatics (3)
Cardiology and Cardiovascular Medicine (2)
Complementary and Alternative Medicine (2)
Geriatrics and Gerontology (2)
Genetics (clinical) (1)
Histology (1)
Immunology and Allergy (1)
Microbiology (medical) (1)
Oncology (1)
Pathology and Forensic Medicine (1)
Immunology and Microbiology (8)
Immunology and Microbiology (miscellaneous) (5)
Immunology (2)
Microbiology (1)
Pharmacology, Toxicology and Pharmaceutics (8)
Drug Discovery (4)
Pharmaceutical Science (3)
Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (3)
Pharmacology (1)
Chemical Engineering (7)
Catalysis (4)
Chemical Engineering (miscellaneous) (3)
Chemistry (7)
Organic Chemistry (6)
Physical and Theoretical Chemistry (6)
Inorganic Chemistry (4)
Spectroscopy (4)
Chemistry (miscellaneous) (3)
Analytical Chemistry (2)
Neuroscience (6)
Neuroscience (miscellaneous) (5)
Cellular and Molecular Neuroscience (1)
Computer Science (5)
Computer Science Applications (5)
Health Professions (3)
Medical Laboratory Technology (3)
Multidisciplinary (2)
Multidisciplinary (2)
Veterinary (2)
Veterinary (miscellaneous) (2)
Agricultural and Biological Sciences (1)
Food Science (1)
Social Sciences (1)
Library and Information Sciences (1)

Genre chart

Year chart

Language chart